Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer ; volume:13 ; number:1 ; day:11 ; month:10 ; year:2023 ; pages:1-14 ; date:12.2023
Scientific reports ; 13, Heft 1 (11.10.2023), 1-14, 12.2023
- Creator
-
Luan, Hong
Jian, Linge
Huang, Yuyan
Guo, Yutong
Zhou, Liping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44506-8
- URN
-
urn:nbn:de:101:1-2024013114405588736776
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luan, Hong
- Jian, Linge
- Huang, Yuyan
- Guo, Yutong
- Zhou, Liping
- SpringerLink (Online service)
Other Objects (12)
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
EPYC functions as a novel prognostic biomarker for pancreatic cancer
YOD1 serves as a potential prognostic biomarker for pancreatic cancer
Microbiome as a biomarker and therapeutic target in pancreatic cancer
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
CISD3 is a prognostic biomarker and therapeutic target in pan-cancer
ADAMTS13 in pediatric sepsis: a prognostic biomarker with potential therapeutic implications
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
EPYC functions as a novel prognostic biomarker for pancreatic cancer
YOD1 serves as a potential prognostic biomarker for pancreatic cancer
Microbiome as a biomarker and therapeutic target in pancreatic cancer
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
CISD3 is a prognostic biomarker and therapeutic target in pan-cancer
ADAMTS13 in pediatric sepsis: a prognostic biomarker with potential therapeutic implications
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
EPYC functions as a novel prognostic biomarker for pancreatic cancer
YOD1 serves as a potential prognostic biomarker for pancreatic cancer
Microbiome as a biomarker and therapeutic target in pancreatic cancer
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
CISD3 is a prognostic biomarker and therapeutic target in pan-cancer
ADAMTS13 in pediatric sepsis: a prognostic biomarker with potential therapeutic implications
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer